COVID-19 Vaccination programme
Vaccine deployment started on 8 December 2021, in the order of priority set by the independent Joint Committee for Vaccination and Immunisation (JCVI).
The subsequent roll out of the programme has involved different cohorts and at-risk groups as the understanding of the virus and the vaccine has progressed. As such it is not possible to compare the uptake of each stage of the programme as the eligible population is different. Each dose is presented below.
Table 6: COVID-19 vaccination uptake (dose 1 and dose 2), ages 5+ 22 February
| Northeast (mean uptake) | North Tyneside | |
|---|---|---|
| 1st dose | 77.3% | 81.3% |
| 2nd dose | 73.5% | 78.0% |
Table 7: COVID-19 vaccination uptake (dose 3 and spring 2022 booster), age 12+, Northeast LAs, 22 February 2023
| Northeast (mean uptake) | North Tyneside | |
|---|---|---|
| Dose 3 and Spring 2022 booster | 64.7% | 69.5% |
Table 8: COVID-19 vaccination uptake (autumn 2022 booster), age 50+, Northeast LAs, 22 February 2023
| Northeast (mean uptake) | North Tyneside | |
|---|---|---|
| Autumn booster (2022) | 67.9% | 70.6% |
OHID Northeast and Yorkshire COVID-19 weekly briefing
Overall uptake of the COVID-19 vaccine is excellent and compares well regionally and nationally. However, detailed analysis of the programme by the vaccine inequalities sub-group of the North Tyneside vaccination board, highlights a several inequalities in uptake. There is a year-round programme which looks to tackle these inequalities.
Inequalities are evident by:
- Age – older persons uptake is incredibly highly and decreases through the age cohorts.
- Deprivation – wards in more deprived boroughs have lower uptake than the less deprived boroughs. This is becoming more pronounced as the age cohorts lower.
- Vulnerable groups – those on the LD register, SMI register and carers register have lower uptake.